Comparison the value of MAP(ASH) score with Child-Pugh and MELD in prognosis of variceal bleeding in cirrhosis patients
Main Article Content
Keywords
Abstract
Objective: To compare the value of MAP(ASH) score with Child-Pugh (CP) and model of end-stage liver disease (MELD) score in predicting early rebleeding and in-hospital mortality in cirrhosis patients complicated by esophageal variceal bleeding. Subject and method: Cross-sectional description of 222 patients with esophageal variceal bleeding with underlying cirrhosis treated at the Department of Gastrointestinal and Internal Medicine Emergency Department - 103 Military Hospital and Digestive Diseases Treatment Institute - 108 Military Central Hospital. Calculate MAP(ASH), MELD, CP scores at the time of admission, compare with the rate of early rebleeding and in-hospital mortality, thereby determining and comparing the prognosis value of these scores through analysis of area under the curve. Result: The rates of rebleeding and in-hospital mortality were 9.0% and 6.8%, respectively. Regarding the prognosis of early rebleeding, the MAP(ASH) score had good prognostic value (AUROC 0.72; 95%CI: 0.59-0.84), while the CP and MELD scores had poor predictive value with AUROC < 0.70. Regarding prognosis of in-hospital mortality: MAP(ASH), MELD scores all had good value with both AUROC equal to 0.83 (p<0.001), while CP only had medium prognostic value with AUROC 0.79 (95%CI: 0.66-0.92; p<0.05). However, the difference between the MAP(ASH), MELD and CP in prognosis was not statistically significant. Conclusion: MAP(ASH) is a valuable score in predicting in-hospital death as well as early rebleeding in cirrhotic patients with esophageal variceal bleeding, better than CP and MELD scores, so it is necessary to recommended for application in clinical practice.
Article Details
References
2. de Franchis R; Baveno VI Faculty (2015) Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. J Hepatol 63(3): 543-545.
3. Yang L, Sun R, Wei N, Chen H (2021) Systematic review and meta-analysis of risk scores in prediction for the clinical outcomes in patients with acute variceal bleeding. Ann Med 53(1): 1806-1815.
4. Aluizio CLS, Montes CG, Reis GFSR, Nagasako CK (2021) Risk stratification in acute variceal bleeding: Far from an ideal score. Clinics (Sao Paulo) 76: 2921.
5. Redondo-Cerezo E, Vadillo-Calles F, Stanley AJ et al (2020) MAP(ASH): A new scoring system for the prediction of intervention and mortality in upper gastrointestinal bleeding. J Gastroenterol Hepatol 35(1): 82-89.
6. Jimenez-Rosales R, Lopez-Tobaruela JM, Lopez-Vico M, et al (2023) Performance of the New ABC and MAP(ASH) Scores in the Prediction of Relevant Outcomes in Upper Gastrointestinal Bleeding. J. Clin. Med. 12: 1085.
7. Li Y, Lu Q, Wu K et al (2022) Evaluation of six preendoscopy scoring systems to predict outcomes for older adults with upper gastrointestinal bleeding. Gastroenterology Research and Practice, Article ID 9334866.
8. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J et al (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31(4): 864-871.
9. Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC and Williams R (1973) Transection of the oesophagus for bleeding oesophageal varices. The British Journal of Surgery 60(8): 646-649.
10. Tajiri T, Yoshida H, Obara K et al (2010) General rules for recording endoscopic findings of esophagogastric varices (2nd edition). Dig Endosc 22(1): 1-9.
11. de Franchis R, Bosch J, Garcia-Tsao G, Reiberger T, Ripoll C (2022) Baveno VII Faculty. Baveno VII - Renewing consensus in portal hypertension. J Hepatol 76(4): 959-974.
12. Elsafty RE, Elsawy AA, Selim AF, Taha AM (2021) Performance of albumin-bilirubin score in prediction of hepatic encephalopathy in cirrhotic patients with acute variceal bleeding. Egypt Liver J 11(1): 1-7.